Suppression of neuropathic pain in the circadian clock-deficient Per2 m/m mice involves up-regulation of endocannabinoid system.
Wakaba YamakawaSai YasukochiYuya TsurudomeNaoki KusunoseYuta YamaguchiAkito TsurutaNaoya MatsunagaKentaro UshijimaSatoru KoyanagiShigehiro OhdoPublished in: PNAS nexus (2024)
Neuropathic pain often results from injuries and diseases that affect the somatosensory system. Disruption of the circadian clock has been implicated in the exacerbation of the neuropathic pain state. However, in this study, we report that mice deficient in a core clock component Period2 ( Per2 m/m mice) fail to develop tactile pain hypersensitivity even following peripheral nerve injury. Similar to male wild-type mice, partial sciatic nerve ligation (PSL)- Per2 m/m male mice showed activation of glial cells in the dorsal horn of the spinal cord and increased expression of pain-related genes. Interestingly, α1D-adrenergic receptor (α1D-AR) expression was up-regulated in the spinal cord of Per2 m/m mice, leading to increased production of 2-arachidonoylglycerol (2-AG), an endocannabinoid receptor ligand. This increase in 2-AG suppressed the PSL-induced tactile pain hypersensitivity. Furthermore, intraspinal dorsal horn injection of adeno-associated viral vectors expressing α1D-AR also attenuated pain hypersensitivity in PSL-wild-type male mice by increasing 2-AG production. Our findings reveal an uncovered role of the circadian clock in neuropathic pain disorders and suggest a link between α1D-AR signaling and the endocannabinoid system.
Keyphrases
- neuropathic pain
- wild type
- spinal cord
- spinal cord injury
- high fat diet induced
- poor prognosis
- drug induced
- peripheral nerve
- sars cov
- chronic obstructive pulmonary disease
- binding protein
- adipose tissue
- genome wide
- cell proliferation
- endothelial cells
- transcription factor
- type diabetes
- skeletal muscle
- pain management
- oxidative stress
- metabolic syndrome
- gene therapy
- cell cycle arrest